| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 1691.68 | 97 |
| GSM780708 | Untreated after 4 days (C2_1) | 1527.56 | 97 |
| GSM780709 | Untreated after 4 days (C3_1) | 1380.66 | 97 |
| GSM780719 | Untreated after 4 days (C1_2) | 2155.42 | 98 |
| GSM780720 | Untreated after 4 days (C2_2) | 1735.62 | 98 |
| GSM780721 | Untreated after 4 days (C3_2) | 1676.95 | 97 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 1368.81 | 97 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 1923.69 | 98 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 1739.27 | 98 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 1372.59 | 97 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 2288.89 | 98 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 1804.26 | 98 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 1739.27 | 98 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 1551.78 | 97 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 1941.67 | 98 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 2044.09 | 98 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 1801.24 | 98 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 1891.76 | 98 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 2250.15 | 98 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 1943.5 | 98 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 1775.9 | 98 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 2118.16 | 98 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 1812.25 | 98 |